Automated platforms

Future Diagnostics has broad experience with the development of immunoassays and clinical chemistry assays on automated platforms using various detection technologies. We routinely develop assays using the following formats:

Microtiter Plate

Future Diagnostics develops in vitro diagnostic enzyme linked immunosorbent assay (ELISA), or EIA in a microtiter plate format. These diagnostic assays can be performed in almost every research or clinical laboratory. Microtiter plate assays offer a flexible way of setting up a new biomarker assay to perform clinical studies.

Point-of-Care

Future Diagnostics develops assays for point-of-care devices. These assays are typically fast and easy to use, and can be carried out wherever the patient is receiving care.